Infections cause various malignancies like hepatic malignancy associated with Hepatitis B and C virus. This PPT will provide basic details regarding pathogenesis and mutations in infection induced malignancies.
here i discussed some human oncogenic viruses , their epidemeology, life cycle, treatment, prevention and control. . oncogenic viruses are cancer causing viruses.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
here i discussed some human oncogenic viruses , their epidemeology, life cycle, treatment, prevention and control. . oncogenic viruses are cancer causing viruses.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
3. Infections causing cancer
Infections account for 15 to 20% of all malignancies, worldwide.
Preventable cause of malignancy.
Viral infection – most common. It causes malignancy by
1. Production of Viral oncoproteins
2. By mutation of proto-oncogenes
3. By viral insertion
4. By chronic inflammation and tissue damage
7. Properties of oncogenic viruses
Causes chronic infection
Evade host immunity
Long latency between the infection and development of malignancy.
8. RNA virus
Human T cell Lymphotropic virus 1
(HTLV1)
Hepatitis C virus
DNA virus
Human Papilloma virus (HPV)
Epstein-Barr virus (EBV)
Kaposi Sarcoma Herpes virus (KSHV)
Hepatitis B virus
9. Human Papilloma Virus
HPV 6 and 11 – low malignant potential. Associated with Genital warts.
HPV 16 & 18 – high malignant potential. Causes squamous cell carcinoma of
cervix and Anogenital region.
20% of oropharyngeal malignancies are also associated with HPV infection.
By production of oncoproteins – E6 and E7.
E7 –binds to retinoblastoma protein (Rb)
E6 – binds to p53 and facilitates degradation of p53.
10.
11. E6 and E7 from HPV 16 &18 (high risk HPV) has highest affinity for p53 and Rb
protein.
HPV infection causes malignancy by,
1. Activation of cyclins
2. Inhibition of tumor suppressors ( p53, p21, p27)
3. Inhibition of apoptosis
13. EBV infects B cells via CD 21 receptor.
Latent Membrane Protein 1 ( LMP1) – EBV encoded gene and it promotes B- cell
proliferation by activating JAK/STAT and NF-kB pathways
Translocation between chromosome 8 and 14, which causes overexpression of
MYC proto oncogene.
Immunocompetent patients – asymptomatic or self limited disease.
In Immunosuppressive conditions such as concomitant malaria or other infections
– causes sustained B cell proliferation.
14.
15.
16. Kaposi sarcoma
Angio-proliferative spindle cell tumor –
derived from endothelial cells and
immune cells.
Human Herpes Virus 8 infection.
Lesions are seen in skin, oral mucosa,
lymph nodes, and visceral organs
17.
18. Types :
1. Classic – occurs as sporadic infection, progressive over 10 to 15 years.
2. Endemic - common in African countries
3. Epidemic or AIDS related ( CD4 <500cells/cu.mm)
4. Iatrogenic – organ transplant related
22. Mechanism
Activation of NF-kB pathway (By mediators from immune cells) – inhibits
apoptosis
Chronic inflammation and tissue damage
Production of reactive oxygen species
Accumulation of mutation and will result in malignant proliferation
23.
24. Helicobacter pylori
Gastric adenocarcinoma
Gastric MALToma
CagA gene is injected into the gastric epithial cells and causes unregulated growth
signals.
Pathology:
1. Chronic inflammation and tissue damage
2. Increased epithelial cell proliferation
28. Multiple Endocrine Neoplasia
MEN 1 syndrome or Wermer syndrome MEN 2 syndrome or Sipple’s syndrome
Mutation:
MEN 1 gene on chromosome 11 RET proto oncogene mutation
1. Pituitary adenoma
2. Hyperparathyroidism
3. Pancreatic neuroendocrine tumours
1. Medullary carcinoma thyroid
2. Pheochromocytoma
3. Parathyroid tumors
29.
30.
31.
32.
33. Summary
HPV – causes cervical cancer. Produces oncoproteins E6 and E7 which binds to
p53 and Rb gene.
EBV – Various B cell lymphomas, Nasopharyngeal carcinoma
Hepatitis B and Hepatitis C – causes chronic hepatitis and cirrhosis. Malignancy
occurs in untreated patients as a result of chronic inflammation.
HTLV1 – retrovirus (like HIV) infects CD4 cells and causes T cell leukemia
34. H. Pylori – CagA gene. Causes gastric adenocarcinoma and MALToma
MEN syndromes – MEN 1 ( chromosome 11) and MEN 2 – RET proto oncogene.
BRCA 1& 2 – breast cancer
Rb gene – retinoblastoma
APC gene – Familial adenomatous polyps or colon cancer